Extended Postoperative Oral Tranexamic Acid in Knee Replacement

• Status: Not yet recruiting
• Trial end date: 2023-11-01
• Target enrollment: 0
• Participant gender: All

Summary

A comparison of outcomes between use of oral tranexamic acid as compared to oral placebo in the first days after total knee replacement will be made to determine impact on clinical indications and patient reported outcomes.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Campbell Clinic
• Treatments: Tranexamic Acid

Criteria

Inclusion Criteria:

• Primary total knee replacement in ambulatory setting

• Willing to participate

• Physical therapy on site at Campbell Clinic Wolf River

• Fluent in oral and written English

Exclusion Criteria:

• Unwilling to participate

• Revision total knee replacement

• Preoperative use of anticoagulants other than 81 mg aspirin

• Previous history of thromboembolic event

• Previous history of cancer other than non-melanoma skin cancers